Ginseng on hyperglycemia: effects and mechanisms

Area of Science:

• Phytochemistry
• Endocrinology
• Metabolic Disorders

Background:

• American ginseng is recognized for its potential to reduce hyperglycemia, suggesting a role in diabetes management.
• Current understanding of American ginseng's therapeutic mechanisms for diabetes is limited due to a lack of standardized root usage.
• Unraveling these mechanisms is crucial for the effective integration of American ginseng into diabetes treatment strategies.

Purpose of the Study:

• To review current knowledge on American ginseng components and their clinical relevance in diabetes.
• To explore the potential mechanisms by which American ginseng impacts hyperglycemia and pancreatic islet cell function.
• To highlight the need for further research into specific active compounds for therapeutic application.

Main Methods:

• Literature review of existing studies on American ginseng and diabetes.
• Analysis of research investigating ginseng's effects on insulin production and pancreatic beta-cell viability.
• Examination of studies on blood glucose reduction in type II diabetes patients and animal models.

Main Results:

• American ginseng has demonstrated an ability to increase insulin production and reduce apoptosis in pancreatic beta-cells.
• Studies indicate that American ginseng can decrease blood glucose levels in type II diabetes patients and streptozotocin-induced diabetic mice.
• Preliminary data suggest ginseng's beneficial effects may involve modulation of mitochondrial function and apoptosis pathways in pancreatic islet cells.

Conclusions:

• American ginseng shows promise as an adjunct therapy for diabetes, potentially by enhancing pancreatic islet cell health and function.
• Standardization of ginseng components is essential for conclusive therapeutic outcomes.
• Identifying specific bioactive compounds in American ginseng is a critical next step for clinical translation and optimizing diabetes treatment.